| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
NEOADJUVANT ABEMACICLIB AND GIREDESTRANT TRIAL IN PATIENTS WITH ER-POSITIVE, HER2-NEGATIVE EARLY BREAST CANCER |
II |
in corso |
Carcinoma mammario |
- SC Oncologia Clinica Sperimentale di Senologia |
|
International Multicenter Real-World Registry for patients with metastatic renal cell carcinoma Meet-URO 33 study (REGAL study) |
NA |
in corso |
carcinoma renale metastatico |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
ANGIOSARCOMA MAMMARIO: CARATTERISTICHE CLINICOPATOLOGICHE E POTENZIALE IMPATTO PROGNOSTICO DEI MARKERS IMMUNOTERAPICI. |
NA |
in corso |
Angiosarcoma mammario |
SC Anatomia Patologica e Citopatologia - |
|
A PHASE 1B/2, MULTICENTER, OPEN-LABEL PLATFORM STUDY OF SELECT IMMUNOTHERAPY COMBINATIONS IN ADULT PARTICIPANTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) WITH HIGH PD-L1 EXPRESSION |
I/II |
in corso |
Cancro del polmone non a piccole cellule |
- SC Sperimentazioni Cliniche |
|
TROPION-Breast05 A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer |
III |
in corso |
CARCINOMA MAMMARIO |
- SC Oncologia Clinica Sperimentale di Senologia |
